Literature DB >> 28630281

Evidence of a Prion-Like Transmission of p53 Amyloid in Saccharomyces cerevisiae.

Shinjinee Sengupta1, Samir K Maji1, Santanu K Ghosh2.   

Abstract

Loss of p53 function is largely responsible for the occurrence of cancer in humans. Aggregation of mutant p53 has been found in multiple cancer cell types, suggesting a role of aggregation in loss of p53 function and cancer development. The p53 protein has recently been hypothesized to possess a prion-like conformation, although experimental evidence is lacking. Here, we report that human p53 can be inactivated upon exposure to preformed fibrils containing an aggregation-prone sequence-specific peptide, PILTIITL, derived from p53, and the inactive state was found to be stable for many generations. Importantly, we provide evidence of a prion-like transmission of these p53 aggregates. This study has significant implications for understanding cancer progression due to p53 malfunctioning without any loss-of-function mutation or occurrence of transcriptional inactivation. Our data might unlock new possibilities for understanding the disease and will lead to rational design of p53 aggregation inhibitors for the development of drugs against cancer.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  aggregation; amyloid; cancer; p53; protein; yeasts

Year:  2017        PMID: 28630281      PMCID: PMC5574041          DOI: 10.1128/MCB.00118-17

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

1.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

2.  The petite mutation in yeast. Loss of mitochondrial deoxyribonucleic acid during induction of petites with ethidium bromide.

Authors:  E S Goldring; L I Grossman; D Krupnick; D R Cryer; J Marmur
Journal:  J Mol Biol       Date:  1970-09-14       Impact factor: 5.469

3.  Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+].

Authors:  Y O Chernoff; S L Lindquist; B Ono; S G Inge-Vechtomov; S W Liebman
Journal:  Science       Date:  1995-05-12       Impact factor: 47.728

4.  Loss of p53 function in colon cancer cells results in increased phosphocholine and total choline.

Authors:  Noriko Mori; Robert Delsite; Kshama Natarajan; Mariola Kulawiec; Zaver M Bhujwalla; Keshav K Singh
Journal:  Mol Imaging       Date:  2004-10       Impact factor: 4.488

Review 5.  New insights into prion structure and toxicity.

Authors:  David A Harris; Heather L True
Journal:  Neuron       Date:  2006-05-04       Impact factor: 17.173

6.  Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer.

Authors:  Martina Kluth; Silvia Harasimowicz; Lia Burkhardt; Katharina Grupp; Antje Krohn; Kristina Prien; Jovisa Gjoni; Thomas Haß; Rami Galal; Markus Graefen; Alexander Haese; Ronald Simon; Julia Hühne-Simon; Christina Koop; Jan Korbel; Joachim Weischenfeld; Hartwig Huland; Guido Sauter; Alexander Quaas; Waldemar Wilczak; Maria-Christina Tsourlakis; Sarah Minner; Thorsten Schlomm
Journal:  Int J Cancer       Date:  2014-04-26       Impact factor: 7.396

7.  A versatile toolbox for PCR-based tagging of yeast genes: new fluorescent proteins, more markers and promoter substitution cassettes.

Authors:  Carsten Janke; Maria M Magiera; Nicole Rathfelder; Christof Taxis; Simone Reber; Hiromi Maekawa; Alexandra Moreno-Borchart; Georg Doenges; Etienne Schwob; Elmar Schiebel; Michael Knop
Journal:  Yeast       Date:  2004-08       Impact factor: 3.239

8.  Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors.

Authors:  U M Moll; M LaQuaglia; J Bénard; G Riou
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

Review 9.  Cross currents in protein misfolding disorders: interactions and therapy.

Authors:  Rodrigo Morales; Kristi M Green; Claudio Soto
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-11       Impact factor: 4.388

10.  Blocking of p53-Snail binding, promoted by oncogenic K-Ras, recovers p53 expression and function.

Authors:  Sun-Hye Lee; Su-Jin Lee; Yeon Sang Jung; Yongbin Xu; Ho Sung Kang; Nam-Chul Ha; Bum-Joon Park
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

View more
  3 in total

Review 1.  How Do Yeast Cells Contend with Prions?

Authors:  Reed B Wickner; Herman K Edskes; Moonil Son; Songsong Wu; Madaleine Niznikiewicz
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

2.  Molecular basis of the scalp-ear-nipple syndrome unraveled by the characterization of disease-causing KCTD1 mutants.

Authors:  Giovanni Smaldone; Nicole Balasco; Luciano Pirone; Daniela Caruso; Sonia Di Gaetano; Emilia Maria Pedone; Luigi Vitagliano
Journal:  Sci Rep       Date:  2019-07-19       Impact factor: 4.379

3.  A Protein in the Yeast Saccharomyces cerevisiae Presents DNA Binding Homology to the p53 Checkpoint Protein and Tumor Suppressor.

Authors:  Kanwal Farooqi; Marjan Ghazvini; Leah D Pride; Louis Mazzella; David White; Ajay Pramanik; Jill Bargonetti; Carol Wood Moore
Journal:  Biomolecules       Date:  2020-03-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.